PhD in Life sciences in 2015 on Stem cell biology and Genome-wide studies on remodeling factor followed by a business degree in Pharmaceutical and Biotechnology Management (2017). Current position as a Business Development Officer at Genethon since September 2017. 

Amir Hefni is Vice President and Global Commercial Head for Cell & Gene, having joined Novartis in May 2020.He is accountable for developing and implementing Go To Market commercial strategy for all CAR-T products across indications and disease areas.Amir joined Novartis from Ipsen, where he...